Echo Therapeutics, Inc. SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease)

Echo Therapeutics, Inc. SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease)

Echo Therapeutics, Inc. reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease) of $7.90 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-30.

Discontinued › Notes

us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease · last filed 2016-03-30

• Echo Therapeutics, Inc. sec schedule, 12-09, valuation allowances and reserves, period increase (decrease) for fiscal 2015 was $7.90M, a 184.78% increase from fiscal 2014.
• Echo Therapeutics, Inc. sec schedule, 12-09, valuation allowances and reserves, period increase (decrease) for fiscal 2014 was $2.77M, a 69.95% decline from fiscal 2013.
• Echo Therapeutics, Inc. sec schedule, 12-09, valuation allowances and reserves, period increase (decrease) for fiscal 2013 was $9.23M, a 84.60% increase from fiscal 2012.
• Echo Therapeutics, Inc. sec schedule, 12-09, valuation allowances and reserves, period increase (decrease) for fiscal 2012 was $5.00M.